Last updated: 22 August 2024 at 6:21pm EST

Robert C. Blanks Net Worth




The estimated Net Worth of Robert Blanks is at least $2.77 Million dollars as of 20 August 2024. Mr Blanks owns over 4,969 units of Ardelyx Inc stock worth over $1,903,398 and over the last 4 years he sold ARDX stock worth over $862,367.

Mr Blanks ARDX stock SEC Form 4 insiders trading

Mr has made over 24 trades of the Ardelyx Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 4,969 units of ARDX stock worth $29,118 on 20 August 2024.

The largest trade he's ever made was selling 100,000 units of Ardelyx Inc stock on 5 October 2022 worth over $150,000. On average, Mr trades about 11,632 units every 48 days since 2020. As of 20 August 2024 he still owns at least 319,362 units of Ardelyx Inc stock.

You can see the complete history of Mr Blanks stock trades at the bottom of the page.





Mr. Robert C. Blanks biography

Robert C. Blanks is the Chief Regulatory Affairs & Quality Assurance Officer at Ardelyx Inc.



How old is Mr Blanks?

Mr Blanks is 61, he's been the Chief Regulatory Affairs & Quality Assurance Officer of Ardelyx Inc since . There are 2 older and 17 younger executives at Ardelyx Inc. The oldest executive at Ardelyx Inc is Gordon Ringold, 69, who is the Independent Director.

What's Mr Blanks's mailing address?

Robert's mailing address filed with the SEC is C/O ARDELYX, INC., 400 FIFTH AVENUE, SUITE 210, WALTHAM, MA, 02451.

Insiders trading at Ardelyx Inc

Over the last 10 years, insiders at Ardelyx Inc have traded over $37,312,621 worth of Ardelyx Inc stock and bought 85,247,838 units worth $820,614,871 . The most active insiders traders include Forest Baskett, Scott D Sandell, and Anthony A. Jr. Florence. On average, Ardelyx Inc executives and independent directors trade stock every 12 days with the average trade being worth of $1,784,764. The most recent stock trade was executed by Michael Raab on 27 August 2024, trading 7,500 units of ARDX stock currently worth $46,650.



What does Ardelyx Inc do?

ardelyx is focused on enhancing the way people with renal diseases are treated by developing first-in-class medicines. ardelyx's renal pipeline includes the phase 3 development of tenapanor for the treatment of hyperphosphatemia in people with end-stage renal disease who are on dialysis and rdx013, a potassium secretagogue program for the potential treatment of high potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease. in addition, ardelyx has completed phase 3 development of tenapanor for the treatment of irritable bowel syndrome with constipation and anticipates submitting a new drug application to the u.s. food and drug administration for this indication in the second half of 2018. to efficiently bring its treatments to market, ardelyx is pursing strategic collaborations in the u.s. and other countries, including through established agreements with kyowa hakko kirin in japan, fosun pharma in china and knight therapeutics in canada.



What does Ardelyx Inc's logo look like?

Ardelyx Inc logo

Complete history of Mr Blanks stock trades at Ardelyx Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
20 Aug 2024 Robert Blanks
See Remarks
Sale 4,969 $5.86 $29,118
20 Aug 2024
319,362
21 Jun 2024 Robert Blanks
See Remarks
Sale 38,000 $5.96 $226,480
21 Jun 2024
324,331
21 May 2024 Robert Blanks
See Remarks
Sale 4,855 $7.81 $37,918
21 May 2024
362,331
20 Feb 2024 Robert Blanks
See Remarks
Sale 5,017 $8.75 $43,899
20 Feb 2024
368,186
20 Nov 2023 Robert Blanks
See Remarks
Sale 2,835 $4.36 $12,361
20 Nov 2023
260,453
21 Aug 2023 Robert Blanks
See Remarks
Sale 2,846 $3.55 $10,103
21 Aug 2023
263,288
23 Jun 2023 Robert Blanks
See Remarks
Option 33,333 $3.42 $113,999
23 Jun 2023
299,467
23 May 2023 Robert Blanks
See Remarks
Sale 2,835 $3.65 $10,348
23 May 2023
266,134
21 Feb 2023 Robert Blanks
See Remarks
Sale 3,394 $3.00 $10,182
21 Feb 2023
268,969
22 Nov 2022 Robert Blanks
See Remarks
Sale 1,464 $1.95 $2,855
22 Nov 2022
194,363
5 Oct 2022 Robert Blanks
See Remarks
Sale 100,000 $1.50 $150,000
5 Oct 2022
195,827
26 Aug 2022 Robert Blanks
See Remarks
Sale 21,842 $1.04 $22,716
26 Aug 2022
295,827
22 Aug 2022 Robert Blanks
See Remarks
Sale 1,458 $0.98 $1,429
22 Aug 2022
317,669
26 Jul 2022 Robert Blanks
See Remarks
Sale 5,188 $0.67 $3,476
26 Jul 2022
319,127
6 Jun 2022 Robert Blanks
See Remarks
Sale 73,312 $0.65 $47,653
6 Jun 2022
324,315
20 May 2022 Robert Blanks
See Remarks
Sale 1,489 $0.67 $998
20 May 2022
397,627
22 Feb 2022 Robert Blanks
See Remarks
Sale 1,752 $0.67 $1,174
22 Feb 2022
399,116
22 Nov 2021 Robert Blanks
See Remarks
Sale 643 $0.99 $637
22 Nov 2021
360,868
20 Aug 2021 Robert Blanks
See Remarks
Sale 631 $1.32 $833
20 Aug 2021
106,323
20 May 2021 Robert Blanks
See Remarks
Sale 612 $7.09 $4,339
20 May 2021
106,954
6 Apr 2021 Robert Blanks
See Remarks
Sale 5,163 $8.00 $41,304
6 Apr 2021
107,566
22 Feb 2021 Robert Blanks
See Remarks
Sale 593 $6.88 $4,080
22 Feb 2021
112,729
15 Sep 2020 Robert Blanks
See Remarks
Sale 34,685 $5.45 $189,033
15 Sep 2020
80,710
1 Sep 2020 Robert Blanks
See Remarks
Sale 2,049 $5.58 $11,433
1 Sep 2020
115,395


Ardelyx Inc executives and stock owners

Ardelyx Inc executives and other stock owners filed with the SEC include: